McMasters, K.M., Wong, S.L., Chao, C.C., Woo, C., Tuttle, T.M., Noyes, R.D., Carlson, D.J., Laidley, A.L., McGlothin, T.Q., Ley, P.B., Brown, C.M., Glaser, R.L., Pennington, R.E., Turk, P.S., Simpson, D., Edwards, M.J. and University of Louisville Breast Cancer Study Group (2001) Defining the of Optimal Surgeon Experience for Breast Cancer Sentinel Lymph Node Biopsy: A Model for Implementation of New Surgical Techniques. Annals of Surgery, 234, 292-300.
https://doi.org/10.1097/00000658-200109000-00003

has been cited by the following article:

• TITLE: The Role of 18F-FDG PET/CT in Staging Breast Carcinoma in Hanoi Oncology Hospital, Vietnam

  AUTHORS: Cuong Duy Dang, Thang Van Nguyen, Tuynh Van Chu, Huy Quang Pham

  KEYWORDS: 18F-FDG PET/CT (Positron Emission Tomography with 2-Deoxy-2-[Fluorine-18]Fluoro-D-Glucose Integrated with Computed Tomography), Breast Carcinoma, Staging, SUV (Standardized Uptake Value)

  JOURNAL NAME: Journal of Biosciences and Medicines, Vol.10 No.1, January 27, 2022

  ABSTRACT: Purpose: This study aimed to evaluate the role of 18F-FDG PET/CT scans in staging breast carcinoma. Materials and Methods: A descriptive study on 46 patients who were diagnosed with breast carcinoma in Hanoi Oncology Hospital, Vietnam from June 2019 to June 2021. Those patients underwent 18F-FDG PET/CT scans for pre-treatment staging. Results: There was a positive correlation between the size of primary tumors and their SUV (p 18F-FDG PET/CT were 75% and 100%, respectively. The rate of distant metastasis detection was 15.2% (7/46 patients). Metastatic lesions were found in bone, lungs, liver, and lymph nodes. There was a significant difference in SUV among organs (p 18F-FDG PET/CT. After PET/CT, 17.4% patients (8/46) had their treatment plan changed. Conclusions: 18F-FDG PET/CT plays an important role in staging breast carcinoma. Determining accurately the breast carcinoma stage by 18F-FDG PET/CT could help alter treatment strategy to best suit with patients, and avoid unnecessary surgery.